Studies on the role of liver cytochrome P-450 and oestradiol metabolism in the effects of nutrition and phenobarbital on ovulation rate in the ewe.
Coopworth ewes were differentially fed to produce 60 heavy (62 kg) and 80 light (45 kg) ewes. They were then fed a low protein (100 g protein kg-1 dry matter) pelleted ration. On Day 7 of the oestrous cycle after synchronization the following treatments were commenced in groups of 10 ewes: 4 low liveweight groups received low protein (LP), high protein (HP; 230 g protein kg-1 dry matter), LP + phenobarbital (PB; 1 g per os per day in gelatin capsules for 10 days) and LP + triacetyloleandomycin (TAO, 0.5 g day-1 in capsule for 10 days); while 3 high liveweight groups received LP, HP and HP + carbon tetrachloride (CCl4, 0.1 mL kg-1 bodyweight as a single dose). The experiment was repeated using another 7 groups of 10 ewes at an interval of 3 weeks. PB, TAO, high liveweight, and protein diet increased the ovulation rate whereas treatment with CCl4 reduced the ovulation rate. Because of the small number of ewes in some treatment protocols, only changes due to liveweight and protein diet were statistically significant. Liver weight and microsomal protein were increased by all treatments except CCl4 which caused a decrease. PB and TAO increased cytochrome P-450 and associated enzyme activities, in particular those related to cytochrome P-450p or P-450NF (including oestradiol 2-hydroxylation) in the human liver. In vitro, TAO binding indicated that the specific cytochrome was induced by PB and TAO but there were no direct effects of protein diet and liveweight. Most of the data support the theory that nutritionally induced increases in ovulation rate in ewes could result from changes in oestradiol metabolism, but the lack of induction of the specific cytochrome by protein diet and high liveweight suggests that increased ovulation caused by these factors may be the physiological response to several metabolic changes.
Payne
E
E
MAF Technology, Ruakura Agricultural Centre, Hamilton, New Zealand.
Smith
J F
JF
Cope
B C
BC
McGowan
L T
LT
D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D002251:Carbon Tetrachloride / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D004958:Estradiol / Q000378:metabolism*; D005260:Female; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D010060:Ovulation / Q000187:drug effects / Q000502:physiology*; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology*; D012756:Sheep / Q000502:physiology*; D014217:Troleandomycin / Q000378:metabolism / Q000494:pharmacology
D004958:Estradiol; D003577:Cytochrome P-450 Enzyme System; D014217:Troleandomycin; D002251:Carbon Tetrachloride; D010089:Oxidoreductases, N-Demethylating; D010634:Phenobarbital